Topic: News & Events

April 2024

NATIONAL ADVISORY COMMITTEE OF IMMUNIZATION (NACI) RAPID RESPONSE: ADDITIONAL DOSE OF COVID-19 VACCINE IN IMMUNOCOMPROMISED INDIVIDUALS FOLLOWING 1- OR 2- DOSE PRIMARY SERIES

Please visit https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/statement-september-10-2021-additional-dose-covid-19-vaccine-immunocompromised-following-1-2-dose-series.html for details.

< Back to Main List Next Article >

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Scientists say they have identified a root cause of lupus — one that could pave the way for new treatments

Advocacy & Support Community & Awareness

Belimumab (Benlysta) Now Approved in Saskatchewan, Nova Scotia, and New Brunswick for Lupus Nephritis

Advocacy & Support Community & Awareness

Megakaryocyte: a new player in systemic lupus erythematosus

News & Events Research & Clinical Trials